https://www.selleckchem.com/pr....oducts/oicr-9429.htm
Plasma ANXA1 levels indicate an increase in paracrine release in patients with LL. The data indicate that ANXA1 expression is enhanced in the leukocytes and plasma of patients with LL, and may contribute to the inhibition of leukocyte action, leading to inadequate functioning of the immune system and thus contributing to the spread of M. leprae infection. The data indicate that ANXA1 expression is enhanced in the leukocytes and plasma of patients with LL, and may contribute to the inhibition of leukocyte action, leading to inadequate
Like
Comment
Share
